Emerging antibiotic resistance

Journal of Laboratory and Clinical Medicine

Volumn 130, Issue 6, 1997, Pages 558-566

  Bonafede, Mary ^b   Rice, Louis B ^a  

^a LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031474287     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(97)90105-0     Document Type: Review

References (28)

1. Livermore DM. Interplay of impermeability and chromosomal β-lactamase activity in imipenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 1992;36: 2046-8.
2. Ambler RP, Coulson AFW, Frère JM, et al. A standard numbering scheme for the class A β-lactamases. Biochem J 1991;276:269-72.
3. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995;39:1211-33.
4. Du Bois SK, Marriott MS, Amyes SGB. TEM- and SHV-derived extended-spectrum β-lactamases: relationship between selection, structure and function. J Antimicrob Chemother 1995;35:7-22.
5. Rice LB, Yao JDC, Klimm K, Eliopoulos GM, Moellering Jr RC. Efficacy of different β-lactams against an extended spectrum β-lactamase-producing Klebsiella pneumoniae strain in the rat intraabdominal abscess model. Antimicrob Agents Chemother 1991;35:1243-4.
6. Karas JA, Pillay DG, Muckart D, Sturm AW. Treatment failure due to extended-spectrum βlactamase. J Antimicrob Chemother 1996;37:203-4.
7. Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993;119:353-8.
8. Rice LB, Eckstein EC, DeVente J, Shlaes DM. Ceftazidimeresistance Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 1996;23:118-24.
9. Schiappa DA, Hayden MK, Matushek MG, et al. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. Infect Dis 1996;174:529-36.
10. Jett BD, Ritchie DJ, Reichley R, Bailey TC, Sahm DF. In vitro activities of various βlactam antimicrobial agents against clinical isolates of Escherichia coli and Klebsiella spp. resistant to oxyamino cephalosporins. Antimicrob Agents Chemother 1995;39:1187-90.
11. Rice LB, Carias LL, Bonomo RA, Shlaes DM. Molecular genetics of resistance to both ceftazidime and β-lactam-β-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to β-lactam therapy. J Infect Dis 1996; 173:151-8.
12. Breiman RF, Butler JC, Tenover FC, Elliott JA, Facklam RR. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994;271:1831-5.
13. Doern GV, Brueggemann A, Holley HP Jr, Rauch AM. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother 1996;40:1208-13.
14. Dowson CG, Coffey TJ, Spratt BG. Origin and molecular epidemiology of penicillin-binding-protein-mediated resistance to β-lactam antibiotics. Trends Microbiol 1994; 2:361-6.
15. Grebe T, Hakenbeck R. Penicillin-binding proteins 2b and 2x of Streptococcus pneumoniae are primary resistance determinants for different classes of β-lactam antibiotics. Antimicrob Agents Chemother 1996;40:829-34.
16. McCracken GH Jr. Emergence of resistant Streptococcus pneumoniae: a problem in pediatrics. Pediatr Infect Dis J 1995;14:424-8.
17. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993;6:428-42.
18. Fontana R, Grossato A, Rossi L, Cheng YR, Satta G. Transition from resistance to hypersusceptibility to β-lactam antibiotics associated with loss of a low affinity penicillin-binding protein in a Streptococcus faecium mutant highly resistant to penicillin. Antimicrob Agents Chemother 1985;28:678-83.
19. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin-United States, 1989-1993. MMWR Morb Mortal Wkly Rep 1993;42:597-9.
20. Arthur M, Courvalin P. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob Agents Chemother 1993;37:1563-71.
21. Arthur M, Molinas C, Depardieu F, Courvalin P. Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol 1993;175:117-27.
22. Quintiliani R Jr, Courvalin P. Characterization of Tn1547, a composite transposon flanked by the IS16 and IS256-like elements, that confers vancomycin resistance in Enterococcus faecium BM4281. Gene 1996;172:1-8.
23. Centers for Disease Control and Prevention. Preventing the spread of vancomycin resistance: report from the Hospital Infection Control Practices Advisory Committee. Federal Register 1994;59:25758-63.
24. Wells CL, Juni BA, Cameron SB, et al. Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients. Clin Infect Dis 1995;21:45-50.
25. Morris JG, Shay DK, Hebden JN, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin: establishment of endemicity in a University medical center. Ann Intern Med 1995;123:250-9.
26. Quale J, Landman D, Saurina G, Atwood E, DiTore V, Patel K. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis 1996;23:1020-5.
27. Linden PK, Pasculle AW, Manez R, et al. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis 1996;22:663-70.
28. Roghmann M-C, Qaiyumi S, Johnson JA, Schwalbe R, Morris JG Jr. Recurrent vancomycin-resistant Enterococcus faecium bacteremia in a leukemia patient who was persistently colonized with vancomycin-resistant enterococci for two years. Clin Infect Dis 1997;24:514-5.